CSL shares dip despite new FDA approval

The CSL Ltd (ASX: CSL) share price is slightly in the red today despite some positive news for the company.

Related Keywords

America Bob Lojewski ,Demyelinating Polyneuropathy ,Pro Medicus Ltd ,Drug Administration ,Ramsay Health Care Ltd ,Health Care Index ,Resmed Inc ,Care Index ,Health Care Ltd ,Primary Immunodeficiency ,Chronic Inflammatory Demyelinating Polyneuropathy ,North America Bob Lojewski ,